AI calculations help anticipate out-of-emergency clinic heart failure endurance Kumar Jeetendra | November 9, 2020 Using neighborhood and neighborhood data in combination with existing data sources creates a more precise prediction on a patient’s recovery prospects after an out-of-hospital cardiac arrest (OHCA), according to preliminary study to be presented in the American Heart Association’s Resuscitation Science Symposium 2020. The 2020 meeting will be held virtually, November 14-16, and will feature …
Custom Rabbit & Mouse Recombinant Monoclonal Antibodies Kumar Jeetendra | November 7, 2020 AMSBIO announce a new rabbit and mouse recombinant monoclonal antibody development service based upon a revolutionary technology platform. The DimAb™ development platform is different from traditional hybridoma fusion technologies in that it can directly isolate IgG genes from B cells of immunized animals. Using this novel platform – a number of custom development projects have …
India sees early vaccine dispatch as AstraZeneca conveyances run late Kumar Jeetendra | November 6, 2020 A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to over 1.2 million deaths, roiled markets and disrupted countless lives because it was first identified in China in December. Australia is beefing up its potential arsenal against the pandemic to 135 million …
WHO-drove COVID-19 medication plot copies down on antibodies, steroids and disregards remdesivir Kumar Jeetendra | November 6, 2020 A World Health Organization-led scheme to provide COVID-19 drugs to poor countries is gambling on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated October 30, states the priorities are to secure monoclonal antibodies in a tight market …
Researchers use quality treatment to recover harmed optic nerve filaments Kumar Jeetendra | November 5, 2020 Scientists have used gene therapy to regenerate damaged nerve fibers from the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the main causes of blindness worldwide. Axons – nerve pathways – in the adult central nervous system (CNS) do not normally regenerate after injury and disease, meaning …
ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution Kumar Jeetendra | November 5, 2020 ‘s-Hertogenbosch, The Netherlands – November 5, 2020 – Life Science Newswire – ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, today announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM’s …
Australia arranges more COVID-19 antibodies for absolute of 135 million portions Kumar Jeetendra | November 5, 2020 AstraZeneca, the British drugmaker working on a few of the world’s leading COVID-19 vaccine candidates, conquer third-quarter sales estimates on Thursday and revealed it expects data from late-stage trials of the vaccine later this year. The business has taken on the evolution of Oxford University’s potential COVID-19 vaccine, scoring billions in financing and signing multiple …
Aster RV Hospital Launches Aster Breast Clinic with World Class Facilities Kumar Jeetendra | November 4, 2020 Bangalore, 04 November 2020: Aster RV Hospital, a multi-specialty quaternary care hospital in Bengaluru, launched the Aster RV Breast Clinic in the city ahead of National Cancer Awareness Day. A dedicated center for women, the exclusive Breast Clinic will be led by a team of specialized doctors with vast experience in breast disorders and breast …
Engineered counter acting agent may forestall Covid from contaminating human cells Kumar Jeetendra | November 4, 2020 By screening hundreds of artificial antibodies, researchers at Karolinska Institutet in Sweden and EMBL Hamburg in Germany have identified an antibody that may prevent the new coronavirus from infecting human cells. The analysis, which is printed in the journal Nature Communications, also reveals how electrons can be quickly generated in the event of future pandemics. …
Improving affectability of fluid biopsy utilizing ‘inexactly stacked’ identification layers Kumar Jeetendra | November 4, 2020 By detecting DNA fragments in body fluids like urine, some kinds of cancer may already be tracked in an early stage. But in order to capture them, detection sensitivity must be improved. Researchers at the University of Twente in The Netherlands (MESA+ Institute) use electrically charged polymers for this. Not only one layer of this, …
Blood vessel deformities start in vein cells Kumar Jeetendra | November 3, 2020 In the condition called cavernoma, lesions appear in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can now reveal, at molecular level, these changes originate in vein cells. This new understanding of the condition creates possibility of developing better treatments for patients. The study was published in …
South African firm Aspen Pharmacare and Johnson and Johnson strike immunization bargain Kumar Jeetendra | November 3, 2020 South African pharmaceutical company Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it’s accepted in South Africa and internationally. In a statement issued on Monday, Aspen said that if ongoing trials bring global health authorities to endorse the J&J vaccine as safe and effective, …
